Mattia Rediti

HER2-Low Breast Cancer: Molecular Characteristics and Prognosis

Elisa Agostinetto, Mattia Rediti, Danai Fimereli et al. · Cancers · 2021 · 285 citations · Full text

Medicine, Cancer Biology, Oncology +16

Spatial transcriptomics reveals substantial heterogeneity in triple-negative breast cancer with potential clinical implications

Xiaoxiao Wang, David Venet, Frédéric Lifrange et al. · Nature Communications · 2024 · 83 citations · Full text

Medicine, Cancer Biology, Oncology +17

Baseline plasma levels of soluble PD-1, PD-L1, and BTN3A1 predict response to nivolumab treatment in patients with metastatic renal cell carcinoma: a step toward a biomarker for therapeutic decisions

Lorena Incorvaia, Daniele Fanale, Giuseppe Badalamenti et al. · OncoImmunology · 2020 · 82 citations · Full text

Life Sciences, Immunology, Oncology +17

Biweekly sunitinib regimen reduces toxicity and retains efficacy in metastatic renal cell carcinoma: A single‐center experience with 31 patients

Bruno Neri, Agnese Vannini, Marco Brugia et al. · International Journal of Urology · 2012 · 49 citations · Full text

Medicine, Oncology, Pharmacology +13

Early Post-treatment Prostate-specific Antigen at 4 Weeks and Abiraterone and Enzalutamide Treatment for Advanced Prostate Cancer: An International Collaborative Analysis

Pasquale Rescigno, David Dolling, Vincenza Conteduca et al. · European Urology Oncology · 2019 · 25 citations · Full text

Medicine, Oncology, Urology +17